GENETIC PREDICTORS OF ATRIAL FIBRILLATION

Atrial fibrillation (AF) is the most common heart rhythm disturbance. It is believed that the primary form of AF is genetically determined in most cases, but the genetic component cannot be excluded in the secondary form of AF. AF is a heterogeneous disease and many authors proved its relationship w...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Kuskaeva, S. Yu. Nikulina, A. A. Chernova, N. V. Aksyutina
Format: Article
Language:English
Published: Столичная издательская компания 2016-06-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/1278
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227740662726656
author A. V. Kuskaeva
S. Yu. Nikulina
A. A. Chernova
N. V. Aksyutina
author_facet A. V. Kuskaeva
S. Yu. Nikulina
A. A. Chernova
N. V. Aksyutina
author_sort A. V. Kuskaeva
collection DOAJ
description Atrial fibrillation (AF) is the most common heart rhythm disturbance. It is believed that the primary form of AF is genetically determined in most cases, but the genetic component cannot be excluded in the secondary form of AF. AF is a heterogeneous disease and many authors proved its relationship with other genetic heart disease. In most cases, certain combinations of polymorphisms of different genes promote the development of AF. The study of genes of renin-angiotensin-aldosterone system (RAAS) is especially important, because the role of this system in AF pathogenesis is currently studding most intensively. These studies are of great practical interest, as associative effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the prevention of AF is revealed. RAAS blockers are able not only to reduce the risk of new-onset AF in hypertensive and normotensive patients but also prevent recurrence of AF. Furthermore, experimental studies showed that RAAS blockers prevent not only the remodeling of the left ventricle, and also the left atrium, pointing to the pathogenesis of AF. So, screening for susceptibility genes and the study of their polymorphism is currently an important focus in the study of AF.
format Article
id doaj-art-97dbcf2b34114fe5b1eccaeab11ed76b
institution Kabale University
issn 1819-6446
2225-3653
language English
publishDate 2016-06-01
publisher Столичная издательская компания
record_format Article
series Рациональная фармакотерапия в кардиологии
spelling doaj-art-97dbcf2b34114fe5b1eccaeab11ed76b2025-08-23T10:00:27ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-06-0112333133610.20996/1819-6446-2016-12-3-331-3361226GENETIC PREDICTORS OF ATRIAL FIBRILLATIONA. V. Kuskaeva0S. Yu. Nikulina1A. A. Chernova2N. V. Aksyutina3Krasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky. Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022 RussiaKrasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky. Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022 RussiaKrasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky. Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022 RussiaKrasnoyarsk State Medical University named after Professor V.F. Voyno-Yasenetsky. Partizana Zheleznyaka ul. 1, Krasnoyarsk, 660022 RussiaAtrial fibrillation (AF) is the most common heart rhythm disturbance. It is believed that the primary form of AF is genetically determined in most cases, but the genetic component cannot be excluded in the secondary form of AF. AF is a heterogeneous disease and many authors proved its relationship with other genetic heart disease. In most cases, certain combinations of polymorphisms of different genes promote the development of AF. The study of genes of renin-angiotensin-aldosterone system (RAAS) is especially important, because the role of this system in AF pathogenesis is currently studding most intensively. These studies are of great practical interest, as associative effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the prevention of AF is revealed. RAAS blockers are able not only to reduce the risk of new-onset AF in hypertensive and normotensive patients but also prevent recurrence of AF. Furthermore, experimental studies showed that RAAS blockers prevent not only the remodeling of the left ventricle, and also the left atrium, pointing to the pathogenesis of AF. So, screening for susceptibility genes and the study of their polymorphism is currently an important focus in the study of AF.https://www.rpcardio.online/jour/article/view/1278atrial fibrillationcandidate generenin-angiotensin-aldosterone systemace gene i/d polymorphismsagtr1 gene a1166c polymorphismagt gene т174м and м235т polymorphisms
spellingShingle A. V. Kuskaeva
S. Yu. Nikulina
A. A. Chernova
N. V. Aksyutina
GENETIC PREDICTORS OF ATRIAL FIBRILLATION
Рациональная фармакотерапия в кардиологии
atrial fibrillation
candidate gene
renin-angiotensin-aldosterone system
ace gene i/d polymorphisms
agtr1 gene a1166c polymorphism
agt gene т174м and м235т polymorphisms
title GENETIC PREDICTORS OF ATRIAL FIBRILLATION
title_full GENETIC PREDICTORS OF ATRIAL FIBRILLATION
title_fullStr GENETIC PREDICTORS OF ATRIAL FIBRILLATION
title_full_unstemmed GENETIC PREDICTORS OF ATRIAL FIBRILLATION
title_short GENETIC PREDICTORS OF ATRIAL FIBRILLATION
title_sort genetic predictors of atrial fibrillation
topic atrial fibrillation
candidate gene
renin-angiotensin-aldosterone system
ace gene i/d polymorphisms
agtr1 gene a1166c polymorphism
agt gene т174м and м235т polymorphisms
url https://www.rpcardio.online/jour/article/view/1278
work_keys_str_mv AT avkuskaeva geneticpredictorsofatrialfibrillation
AT syunikulina geneticpredictorsofatrialfibrillation
AT aachernova geneticpredictorsofatrialfibrillation
AT nvaksyutina geneticpredictorsofatrialfibrillation